38. Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA, 2012, 307(23): 2526-2533.
[2]
1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med, 2000, 342(18): 1334-1349.
[3]
2. Esteban A, Frutos-Vivar F, Muriel A, et al. Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med, 2013, 188(2): 220-230.
[4]
3. Li G, Malinchoc M, Cartin-Ceba R, et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med, 2011, 183(1): 59-66.
6. Geboers DG, de Beer FM, Tuip-de Boer AM, et al. Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients. Intensive Care Med, 2015, 41(7): 1281-1290.
[8]
7. Adamzik M, Broll J, Steinmann J, et al. An increased alveolar CD4+ CD25 + Foxp3 + T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality. Intensive Care Med, 2013, 39(10): 1743-1751.
[9]
8. Lefran？ais E, Ortiz-Mu？oz G, Caudrillier A, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature, 2017, 544(7648): 105.
[10]
9. Maniatis NA, Letsiou E, Orfanos SE, et al. Inhaled activated protein C protects mice from ventilator-induced lung injury. Crit Care, 2010, 14(2): R70.
[11]
10. Caudrillier A, Kessenbrock K, Gilliss BM, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest, 2012, 122(7): 2661-2671.
[12]
11. Looney MR, Nguyen JX, Hu Y, et al. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest, 2009, 119(11): 3450-3461.
[13]
12. Scheiermann C, Kunisaki Y, Jang JE, et al. Neutrophil microdomains: linking heterocellular interactions with vascular injury. Curr Opin Hematol, 2010, 17(1): 25-30.
[14]
13. Bozza FA, Shah AM, Weyrich AS, et al. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol, 2009, 40(2): 123-134.
[15]
14. Wang TH, Liu Z, Wang ZX, et al. Thrombocytopenia is associated with acute respiratory distress syndrome mortality: an international study. PLoS One, 2014, 9(4): e94124.
[16]
15. Wei, Y, Tejera P, Wang Z, et al. A missense genetic variant in LRRC16A/CARMIL1 improves acute respiratory distress syndrome survival by attenuating platelet count decline. Am J Respir Crit Care Med, 2017, 195(10): 1353-1361.
[17]
16. Wu J, Sheng L, Wang S, et al. Analysis of clinical risk factors associated with the prognosis of severe multiple-trauma patients with acute lung injury. J Emerg Med, 2012, 43(3): 407-412.
[18]
17. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 1994, 149(3): 818.
[19]
18. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest, 2006, 116(12): 3211-3219.
[20]
19. Kiefmann R, Heckel K, Schenkat S, et al. Role of p-selectin in platelet sequestration in pulmonary capillaries during endotoxemia. J Vasc Res, 2006, 43(5): 473-481.
[21]
20. Rice TW, Wheeler AP. Coagulopathy in critically ill patients: part 1: platelet disorders. Chest, 2009, 136(6): 1622-1630.
[22]
21. Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematol Am Soc Hematol Educ Program, 2010, 2010(1): 135-143.
[23]
22. Housinger TA, Brinkerhoff C, Warden GD. The relationship between platelet count, sepsis, and survival in pediatric burn patients. Arch Surg, 1993, 128(1): 65-67.
[24]
23. Lopez-Delgado JC, Rovira A, Esteve F, et al. Thrombocytopenia as a mortality risk factor in acute respiratory failure in H1N1 influenza. Swiss Med Wkly, 2013, 143(16): w13788.
[25]
24. Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med, 2000, 28(6): 1871-1876.
[26]
25. Gong MN, Thompson BT, Williams P, et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med, 2005, 33(6): 1191-1198.
[27]
26. Moreau D, Timsit JF, Vesin A, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest, 2007, 131(6): 1735-1741.
[28]
27. Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med, 2000, 342(18): 1301-1318.
[29]
28. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion, 2003, 43(5): 633-640.
[30]
29. Weyrich AS, Zimmerman GA. Platelets in lung biology. Annu Rev Physiol, 2013, 75: 569-591.
[31]
30. Ortiz-Munoz G, Mallavia B, Bins A, et al. Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood, 2014, 124(17): 2625-2634.
[32]
31. Erlich JM, Talmor DS, Cartin-Ceba R, et al. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest, 2011, 139(2): 289-295.
[33]
32. Kor DJ, Erlich J, Gong MN, et al. Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med, 2011, 39(11): 2393.
[34]
33. O'Neal HR, Jr Koyama T, Koehler EA, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med, 2011, 39(6): 1343.
[35]
34. Chen W, Janz DR, Bastarache JA, et al. Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis. Crit Care Med, 2015, 43(4): 801.
[36]
35. Boyle AJ, Di Gangi S, Hamid UI, et al. Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis. Crit Care, 2015, 19: 109.
[37]
36. Kor DJ, Carter RE, Park PK, et al. Effect of aspirin on development of ARDS in at-risk patients presenting to the emergency department: The LIPS-A Randomized Clinical Trial. JAMA, 2016, 315(22): 2406-2414.
[38]
37. Reilly JP, Christie JD. Is it possible to prevent ARDS?. JAMA, 2016, 315(22): 2403-2405.
